These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 32635537)

  • 41. Developing end-point methods for absolute binding free energy calculation using the Boltzmann-quasiharmonic model.
    Wickstrom L; Gallicchio E; Chen L; Kurtzman T; Deng N
    Phys Chem Chem Phys; 2022 Mar; 24(10):6037-6052. PubMed ID: 35212338
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rigorous Computational and Experimental Investigations on MDM2/MDMX-Targeted Linear and Macrocyclic Peptides.
    Diller DJ; Swanson J; Bayden AS; Brown CJ; Thean D; Lane DP; Partridge AW; Sawyer TK; Audie J
    Molecules; 2019 Dec; 24(24):. PubMed ID: 31847417
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Thermodynamic integration to predict host-guest binding affinities.
    Lawrenz M; Wereszczynski J; Ortiz-Sánchez JM; Nichols SE; McCammon JA
    J Comput Aided Mol Des; 2012 May; 26(5):569-76. PubMed ID: 22350568
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Predicting binding affinities of host-guest systems in the SAMPL3 blind challenge: the performance of relative free energy calculations.
    König G; Brooks BR
    J Comput Aided Mol Des; 2012 May; 26(5):543-50. PubMed ID: 22198474
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Improving the Potential of Mean Force and Nonequilibrium Pulling Simulations by Simultaneous Alchemical Modifications.
    Reif MM; Zacharias M
    J Chem Theory Comput; 2022 Jun; 18(6):3873-3893. PubMed ID: 35653503
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Absolute binding free energy calculations using molecular dynamics simulations with restraining potentials.
    Wang J; Deng Y; Roux B
    Biophys J; 2006 Oct; 91(8):2798-814. PubMed ID: 16844742
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Computational analysis of spiro-oxindole inhibitors of the MDM2-p53 interaction: insights and selection of novel inhibitors.
    Huang W; Cai L; Chen C; Xie X; Zhao Q; Zhao X; Zhou HY; Han B; Peng C
    J Biomol Struct Dyn; 2016; 34(2):341-51. PubMed ID: 25808617
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Detailed potential of mean force studies on host-guest systems from the SAMPL6 challenge.
    Song LF; Bansal N; Zheng Z; Merz KM
    J Comput Aided Mol Des; 2018 Oct; 32(10):1013-1026. PubMed ID: 30143917
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Protein surface roughness accounts for binding free energy of Plasmepsin II-ligand complexes.
    Valdés-Tresanco ME; Valdés-Tresanco MS; Valiente PA; Cocho G; Mansilla R; Nieto-Villar JM
    J Mol Recognit; 2018 Jan; 31(1):. PubMed ID: 28895236
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Thermodynamic and computational studies on the binding of p53-derived peptides and peptidomimetic inhibitors to HDM2.
    Grässlin A; Amoreira C; Baldridge KK; Robinson JA
    Chembiochem; 2009 May; 10(8):1360-8. PubMed ID: 19408261
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of antipsychotic drug fluspirilene as a potential p53-MDM2 inhibitor: a combined computational and experimental study.
    Patil SP; Pacitti MF; Gilroy KS; Ruggiero JC; Griffin JD; Butera JJ; Notarfrancesco JM; Tran S; Stoddart JW
    J Comput Aided Mol Des; 2015 Feb; 29(2):155-63. PubMed ID: 25377899
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Entropy localization in proteins.
    Li DW; Showalter SA; Brüschweiler R
    J Phys Chem B; 2010 Dec; 114(48):16036-44. PubMed ID: 21077640
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Determinants of specificity of MDM2 for the activation domains of p53 and p65: proline27 disrupts the MDM2-binding motif of p53.
    Zondlo SC; Lee AE; Zondlo NJ
    Biochemistry; 2006 Oct; 45(39):11945-57. PubMed ID: 17002294
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The cis conformation of proline leads to weaker binding of a p53 peptide to MDM2 compared to trans.
    Zhan YA; Ytreberg FM
    Arch Biochem Biophys; 2015 Jun; 575():22-9. PubMed ID: 25840370
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Free Energy Calculations Using the Movable Type Method with Molecular Dynamics Driven Protein-Ligand Sampling.
    Liu W; Liu Z; Liu H; Westerhoff LM; Zheng Z
    J Chem Inf Model; 2022 Nov; 62(22):5645-5665. PubMed ID: 36282990
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Exploring the Effectiveness of Binding Free Energy Calculations.
    Mondal D; Florian J; Warshel A
    J Phys Chem B; 2019 Oct; 123(42):8910-8915. PubMed ID: 31560539
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Why is F19Ap53 unable to bind MDM2? Simulations suggest crack propagation modulates binding.
    Dastidar SG; Lane DP; Verma CS
    Cell Cycle; 2012 Jun; 11(12):2239-47. PubMed ID: 22617389
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CHARMM-GUI Ligand Binder for absolute binding free energy calculations and its application.
    Jo S; Jiang W; Lee HS; Roux B; Im W
    J Chem Inf Model; 2013 Jan; 53(1):267-77. PubMed ID: 23205773
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Computational Investigation on the p53-MDM2 Interaction Using the Potential of Mean Force Study.
    Das P; Mattaparthi VSK
    ACS Omega; 2020 Apr; 5(15):8449-8462. PubMed ID: 32337406
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Perspective: Alchemical free energy calculations for drug discovery.
    Mobley DL; Klimovich PV
    J Chem Phys; 2012 Dec; 137(23):230901. PubMed ID: 23267463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.